0 items USD 0.00Search
Your search for "mrrpb5 global acute repetitive seizures drugs market size status forecast 2019 2025" gave back 819845 results.
Market Analysis and Insights: Global Acute Repetitive Seizures Drugs Market The global Acute Repetitive Seizures Drugs market is projected to grow...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Based on product, the market is categorized into USL-261, NRL-1, AZ-002, Diastat Rectal Gel {DRG. The global Acute Repetitive Seizures market was...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Based on product, the market is categorized into USL-261, NRL-1, AZ-002, Diastat Rectal Gel {DRG. Market Analysis and Insights: Global Acute...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Based on product, the market is categorized into USL-261, NRL-1, AZ-002, Diastat Rectal Gel {DRG. Highlights The global Acute Repetitive Seizures...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
Injectable Seizure Drugs Market Segmented By Drug Type such as Fosphenytoin, Midazolam, Carbamazepine, Cenobamate, Gabapentin, Phenytoin, Lamotrigine...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Epilepsy is a disorder of the brain characterized by repeated seizures. A seizure is usually defined as a sudden alteration of behavior due to a...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
An epileptic seizure is a brief episode of signs or symptoms due to abnormally excessive or synchronous neuronal activity in the brain. The global...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Acute intermittent porphyria (AIP), also called Swedish porphyria, pyrroloporphyria, intermittent acute porphyria) is a rare autosomal dominant...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Seizure Treatments market size was valued at US$ million in 2023. With growing demand in downstream market, the Seizure Treatments is...
Catalog:
LPI
March 2024
Price: USD 3,660.00
Swedish porphyria is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Acute Migraine Drugs market size was valued at USD 2165.3 million in 2023 and is forecast to a readjusted size of USD 3473.9 million by...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Acute Ischemic Stroke (CIS), also known as Cerebral Infarction (CI), is due to the occlusion of the Cerebral artery caused by the Infarction of brain...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Gemtuzumab ozogamicin is a drug-linked monoclonal antibody (an antibody-drug conjugate) that was used to treat acute myeloid leukemia from 2000 to...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
